Childhood Cancer Model Atlas

The Childhood Cancer Model Atlas (CCMA), housed at Hudson Institute’s Centre for Cancer Research, leverages the world’s largest collection of paediatric cancer cell lines and AI-powered analytics to drive innovative research and clinical translation.

The CCMA includes more than 400 high-risk paediatric cancer cell lines. This unique and open-source repository was established through the collaboration of nearly 50 leading cancer research institutes, universities, and academic medical centres worldwide.

The CCMA provides a unique, open-source facility to cancer researchers globally, and is available to every paediatric oncologist and childhood cancer researcher. Using the CCMA, researchers can have potential treatments tested and analysed using cutting-edge AI techniques. By facilitating shared ‘big data’ the CCMA is accelerating the discovery of new therapies and biomarkers for childhood cancers.

A world leader in the field of paediatric cancer research, Hudson Institute’s Next Generation Precision Medicine program comprises a multidisciplinary team of researchers and clinicians working to improve survival rates and long-term health outcomes for children with cancer.

READ MORE | Childhood Cancer Program

ccma dashboard
ccma analytical portal
Image of how well different drugs work to combat cancer cells. Image of how well different drugs work to combat cancer cells.
Image of how well different drugs work to combat cancer cells.

Next generation precision medicine program
Childhood Cancer Program